ECS Botanics Holdings ASX:ECS Rapport sur les actions ECS Botanics Holdings Ltd
ASX:ECS Rapport sur les actions
Capitalisation boursière : AU$21.9m
ECS Aperçu des actions ECS Botanics Holdings Ltd se consacre à la culture, à la fabrication et à la vente de produits à base de cannabis médicinal dans le nord-ouest de l'État de Victoria.
Récompenses Analyse des risques Voir tous les contrôles de risques ECS Botanics Holdings Ltd Concurrents Historique des prix et performances
Résumé des plus hauts, des changements et des baisses de prix pour ECS Botanics Holdings Historique des cours de bourse Prix actuel de l'action AU$0.017 Plus haut sur 52 semaines AU$0.029 Plus bas sur 52 semaines AU$0.013 Bêta 1.28 1Variation sur 1 mois -10.53% Variation sur 3 mois 6.25% Variation sur 1 an -26.09% 3Variation sur 3 ans -50.00% Variation sur 5 ans -63.04% Évolution depuis l'introduction en bourse -73.85%
Nouvelles et mises à jour récentes Voir plus de mises à jour
Lacklustre Performance Is Driving ECS Botanics Holdings Ltd's (ASX:ECS) 26% Price Drop Nov 11
ECS Botanics Holdings Ltd, Annual General Meeting, Nov 21, 2024 Oct 03
There's No Escaping ECS Botanics Holdings Ltd's (ASX:ECS) Muted Earnings Despite A 38% Share Price Rise Sep 27
ECS Botanics Holdings Ltd Announces Management Appointments Sep 20
Full year 2024 earnings released: EPS: AU$0.002 (vs AU$0 in FY 2023) Aug 29
New minor risk - Share price stability Aug 28
ECS Botanics Holdings Ltd's (ASX:ECS) Shares Lagging The Market But So Is The Business Aug 12
There Is A Reason ECS Botanics Holdings Ltd's (ASX:ECS) Price Is Undemanding Apr 03
New minor risk - Profit margin trend Mar 06
New minor risk - Shareholder dilution Mar 01
First half 2024 earnings released: EPS: AU$0.001 (vs AU$0.001 loss in 1H 2023) Feb 29 ECS Botanics Holdings Ltd to Report Q2, 2024 Results on Feb 28, 2024 Feb 26
ECS Botanics Holdings Ltd has completed a Follow-on Equity Offering in the amount of AUD 4.000016 million. Feb 23
ECS Botanics Holdings Ltd's (ASX:ECS) Share Price Could Signal Some Risk Sep 06
Full year 2023 earnings released: EPS: AU$0 (vs AU$0.001 loss in FY 2022) Sep 01
New minor risk - Financial data availability Aug 30
ECS Botanics Holdings Ltd, Annual General Meeting, Oct 26, 2023 Aug 25
ECS Botanics Holdings Ltd Launches Investor Hub Jun 14
First half 2023 earnings released: AU$0.001 loss per share (vs AU$0.003 loss in 1H 2022) Mar 03
ECS Botanics Holdings Ltd Announces Resignation of Mr. Alex Keach as Head of Corporate Development and an Executive Director Feb 10
No independent directors Nov 16
Blue Buffalo Pty Ltd has entered into a binding share purchase agreement to acquire ECS Botanics Pty Ltd from ECS Botanics Holdings Ltd (ASX:ECS) for AUD 3 million. Oct 24
Full year 2022 earnings released: AU$0.001 loss per share (vs AU$0.006 loss in FY 2021) Sep 02
ECS Botanics Holdings Ltd, Annual General Meeting, Oct 26, 2022 Aug 26
MD & Executive Director recently bought AU$90k worth of stock Jun 29
ECS Botanics Holdings Ltd Announces Change of Managing Director Jun 15
ECS Botanics Holdings Ltd Announces Executive Changes Jun 14
No independent directors Apr 27
Founder exercised options to buy AU$510k worth of stock. Sep 11
Full year 2021 earnings released: AU$0.006 loss per share (vs AU$0.009 loss in FY 2020) Sep 03
ECS Botanics Holdings Ltd Launches Innovative range of 30ml Terpene Blends May 21 ECS Botanics Holdings Ltd Appoints Nan Maree Schoerie as Director
ECS Botanics Holdings (ASX:ECS) Is In A Good Position To Deliver On Growth Plans Feb 24
First half 2021 earnings released: AU$0.005 loss per share (vs AU$0.008 loss in 1H 2020) Feb 24
ECS Botanics Holdings Ltd Appoints Paul Hanrahan as Site & Cultivation Manager Feb 02
ECS Botanics Holdings Ltd (ASX:ECS) signed a binding term sheet to acquire Murray Meds Pty Ltd, Flowerday Farms Pty Ltd and Flowerday Land Property from Flowerday Holdings Pty Ltd for AUD 7.5 million. Jan 13
ECS Botanics Holdings Ltd Enters into Term Sheet with Medipharm Labs Dec 26
ECS Botanics Holdings Ltd announced that it expects to receive AUD 4 million in funding Dec 13
ECS Provides Medicinal Cannabis Project and Regulatory Update Nov 24
ECS Botanics Holdings Ltd Appoints Damian Wood as Director of Medicinal Cannabis Production Oct 29
ECS Botanics Holdings Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.75 million. Aug 18 Rendement pour les actionnaires ECS AU Pharmaceuticals AU Marché 7D 13.3% 14.7% 1.5% 1Y -26.1% 71.0% 17.3%
Voir le rapport complet des actionnaires
Rendement vs Industrie: ECS a sous-performé le secteur Australian Pharmaceuticals qui a rapporté 71 % au cours de l'année écoulée.
Rendement vs marché: ECS a sous-performé le marché Australian qui a rapporté 17.3 % au cours de l'année écoulée.
Volatilité des prix Is ECS's price volatile compared to industry and market? ECS volatility ECS Average Weekly Movement 15.2% Pharmaceuticals Industry Average Movement 11.9% Market Average Movement 8.5% 10% most volatile stocks in AU Market 17.4% 10% least volatile stocks in AU Market 3.5%
Cours de l'action stable: Le cours de l'action de ECS a été volatil au cours des 3 derniers mois.
Volatilité au fil du temps: La volatilité hebdomadaire de ECS ( 15% ) est restée stable au cours de l'année écoulée, mais reste supérieure à 75 % des actions de Australian.
À propos de l'entreprise ECS Botanics Holdings Ltd se consacre à la culture, à la fabrication et à la vente de produits médicinaux à base de cannabis dans le nord-ouest de l'État de Victoria. L'entreprise est active dans le secteur de l'agriculture. ECS Botanics Holdings Ltd est basée à Murrabit, en Australie.
Afficher plus ECS Botanics Holdings Ltd Résumé des fondamentaux Comment les bénéfices et les revenus de ECS Botanics Holdings se comparent-ils à sa capitalisation boursière ? ECS statistiques fondamentales Capitalisation boursière AU$21.91m Bénéfices(TTM) AU$1.92m Recettes(TTM ) AU$20.03m
Bénéfices et recettes Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM) ECS compte de résultat (TTM ) Recettes AU$20.03m Coût des recettes AU$12.52m Marge brute AU$7.51m Autres dépenses AU$5.60m Les revenus AU$1.92m
Derniers bénéfices déclarés
Jun 30, 2024
Prochaine date de publication des résultats
s/o
Résultat par action (EPS) 0.0015 Marge brute 37.51% Marge bénéficiaire nette 9.56% Ratio dettes/capitaux propres 0%
Quelles ont été les performances à long terme de ECS?
Voir les performances historiques et les comparaisons
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
